Limited Visibility In a 1:1 matched case-control study performed by Chapman et al., patients getting GLP-1 RAs had significantly lower visibility scores during EGD and were 4.62 times more likely to have retained gastric contents compared to patients not on GLP-1 RAs ( p -value 0.025) [23]
Brand-name semaglutide products are manufactured by Novo Nordisk and contain specific inactive ingredients chosen during the drug development process
Expression of the insulin-like growth factor 1receptor (IGF-1R) in breast cancer cells: Evidence for a regulatory role of dolichyl phosphate in the transition from an intracellular to an extracellular IGF-1 pathway
Digital health and remote monitoring Advancements in digital health technologies, such as wearable devices and telemedicine, offer promising avenues for long-term patient management
Malik AH, Andrabi SI, Niayesh M (2008) Pseudo-obstruction with pitch black colona very rare presentation of melanosis coli
Compounding pharmacies and healthcare professionals who offer this medication may be jeopardizing their patients health and infringing on Novo Nordisk's intellectual property rights
